Kit ELISA sandwich Insulin-like Growth Factor Binding Protein 2 (Hu IGFBP2) (human): quantitative assay of Hu IGFBP2 in serum, plasma or cell culture medium.
Kit ELISA sandwich Insulin-like Growth Factor Binding Protein 2 (Hu IGFBP2) (human): quantitative assay of Hu IGFBP2 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu IGFBP2.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
IGFBP2 (insulin-type growth factor binding protein 2) is a member of the ISGBP family that binds various IGF. The IGFBP2 is overexpressed in a wide range of cancers, including glioma, prostate cancer, synovial sarcoma, neuroblastoma, colon cancer, adrenocortical cancer, lung cancer, Wilms tumor and hepatoblastoma. The overexpression of the IGFBP2 is also correlated with the aggressiveness of certain tumours. The IGFBP2 activates the expression of matrix metalloprotease 2, which contributes to cell invasion.
Sensitivity
Sensitivity of the dosage: 20 pg/ml.
Measurement range
Dose range: 8.23-6000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Intradose variation coefficient < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15405023 |
| Specifications |
| Accession number | P18065 |
| Dose range | 8.23-6000 pg/ml |
| Sensitivity of the dosage | 20 pg/ml |
| Calibration range | 20 pg/ml to 6000 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Growth Factors & Receivers |
| Type of sample | Serum, Surnatant, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the cytokines tested: Human BDNF, BLC, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, IGFBP-1, IGFBP-3, IGFBP-4, IGFBP-4, leptin |
| Sufficient for | 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 3485 |
| Gene symbol(s) | IBP2,IGF-BP53 |
| Coefficient of inter-dose variation | < 12 % |
| Coefficient of intra-dose variation | < 10 % |
| Contents of kits | 96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Research disciplines | Signal transduction |
| Synonym | IBP2, IGF-BP53 |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 1 μl; serum, 1 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EHIGFBP2 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.